Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: Implications for Down syndrome

Neurobiology of Disease

Volumn 63, Issue , 2014, Pages 92-106

  Mouton Liger, François ^a   Sahún, Ignasi ^b,c,d   Collin, Thibault ^e   Lopes Pereira, Patricia ^e   Masini, Debora ^b,c,d   Thomas, Sophie ^a   Paly, Evelyne ^a   Luilier, Sabrina ^f   Même, Sandra ^g   Jouhault, Quentin ^a   Bennaï, Soumia ^a   Beloeil, Jean Claude ^g   Bizot, Jean Charles ^f   Hérault, Yann ^e,h,i   Dierssen, Mara ^b,c,d   Créau, Nicole ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^e CNRS   (France)

^f Key Obs SAS   (France)

^g CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^h INSTITUT CLINIQUE DE LA SOURIS   (France)

ⁱ UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cerebellum; Down syndrome; Learning; Pcp4; Transgenic mouse

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IIALPHA; PURKINJE CELL PROTEIN 4; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM DISEASE; CONTROLLED STUDY; DOWN SYNDROME; LEARNING DISORDER; LONG TERM DEPRESSION; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CEREBELLUM; DOWN SYNDROME; LEARNING; PCP4; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CEREBELLUM; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LONG-TERM SYNAPTIC DEPRESSION; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONS; PSYCHOMOTOR PERFORMANCE; QUINOXALINES; REACTION TIME; RECOGNITION (PSYCHOLOGY); SODIUM CHANNEL BLOCKERS; TETRODOTOXIN; VALINE;

EID: 84890824287     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.11.016     Document Type: Article

References (104)

1. Ahmed M.M., Sturgeon X., Ellison M., Davisson M.T., Gardiner K.J. Loss of correlations among proteins in brains of the Ts65Dn mouse model of down syndrome. J. Proteome Res. 2012, 11(2):1251-1263.
2. Aït Yahya-Graison E., Aubert J., Dauphinot L., Rivals I., Prieur M., Golfier G., Rossier J., Personnaz L., Creau N., Bléhaut H., Robin S., Delabar J.M., Potier M.C. Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am. J. Hum. Genet. 2007, 81(3):475-491.
3. Almhdie A., Ferrer-Villena J., Harba R., Lédée R., Léger C., Lopes-Pereira P., Même S. Segmentation of mice cerebral structures: application in trisomy 21. Int. J. Innov. Comput. Appl. 2012, 1:1-8.
4. Amano K., Sago H., Uchikawa C., Suzuki T., Kotliarova S.E., Nukina N., et al. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum. Mol. Genet. 2004, 13:1333-1340.
5. Arlotta P., Molyneaux B.J., Chen J., Inoue J., Kominami R., Macklis J.D. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 2005, 45(2):207-221.
6. Arqué G., Fotaki V., Fernández D., Martínez de Lagrán M., Arbonés M.L., Dierssen M. Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A). PLoS One 2008, 3(7):e2575.
7. Aylward E.H., Habbak R., Warren A.C., Pulsifer M.B., Barta P.E., Jerram M., Pearlson G.D. Cerebellar volume in adults with Down syndrome. Arch. Neurol. 1997, 54(2):209-212.
8. Bastianelli E. Distribution of calcium-binding proteins in the cerebellum. Cerebellum 2003, 2:242-262. (Review).
9. Belichenko N.P., Belichenko P.V., Kleschevnikov A.M., Salehi A., Reeves R.H., Mobley W.C. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J. Neurosci. 2009, 29(18):5938-5948.
10. Berggård T., Arrigoni G., Olsson O., Fex M., Linse S., James P. 140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J. Proteome Res. 2006, 5(3):669-687.
11. Blanco S., Molina F.J., Castro L., Del Moral M.L., Hernandez R., Jimenez A., et al. Study of the nitric oxide system in the rat cerebellum during aging. BMC Neurosci. 2010, 11:78.
12. Borgesius N.Z., van Woerden G.M., Buitendijk G.H., Keijzer N., Jaarsma D., Hoogenraad C.C., Elgersma Y. βCaMKII plays a nonenzymatic role in hippocampal synaptic plasticity and learning by targeting αCaMKII to synapses. J. Neurosci. 2011, 31(28):10141-10148.
13. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254. (7 May).
14. Bramham C.R., Wells D.G. Dendritic mRNA: transport, translation and function. Nat. Rev. Neurosci. 2007, 8(10):776-789. (Review).
15. Bulfone A., Caccioppoli C., Pardini C., Faedo A., Martinez S., Banfi S. Pcp4l1, a novel gene encoding a Pcp4-like polypeptide, is expressed in specific domains of the developing brain. Gene Expr. Patterns 2004, 4(3):297-301.
16. Burgin K.E., Waxham M.N., Rickling S., Westgate S.A., Mobley W.C., Kelly P.T. In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain. J. Neurosci. 1990, 10(6):1788-1798.
17. Bussy G., Charrin E., Brun A., Curie A., des Portes V. Implicit procedural learning in fragile X and Down syndrome. J. Intellect. Disabil. Res. 2011, 55(5):521-528.
18. Buxhoeveden D., Casanova M.F. Accelerated maturation in brains of patients with Down syndrome. J. Intellect. Disabil. Res. 2003, 48:705-706.
19. Cabin D.E., Gardiner K., Reeves R.H. Molecular genetic characterization and comparative mapping of the human PCP4 gene. Somat. Cell Mol. Genet. 1996, 22(3):167-175.
20. Carletti B., Rossi F. Neurogenesis in the cerebellum. Neuroscientist 2008, 14(1):91-100. (Feb., Review).
21. Casado M., Dieudonné S., Ascher P. Presynaptic N-methyl-d-aspartate receptors at the parallel fiber-Purkinje cell synapse. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(21):11593-11597.
22. Casado M., Isope P., Ascher P. Involvement of presynaptic N-methyl-d-aspartate receptors in cerebellar long-term depression. Neuron 2002, 33(1):123-130.
23. Chin D., Means A.R. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000, 10(8):322-328. (Review. Erratum in: Trends Cell Biol 2000;10(10):428).
24. Costa A.C., Walsh K., Davisson M.T. Motor dysfunction in a mouse model for Down syndrome. Physiol. Behav. 1999, 68(1-2):211-220.
25. Créau N. Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics. Neural Plast. 2012, 2012:171639. (Review).
26. Crépel F. Role of presynaptic kainate receptors at parallel fiber-Purkinje cell synapses in induction of cerebellar LTD: interplay with climbing fiber input. J. Neurophysiol. 2009, 10(2):965-973.
27. Das I., Park J.M., Shin J.H., Jeon S.K., Lorenzi H., Linden D.J., Worley P.F., Reeves R.H. Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci. Transl. Med. 2013, 5(201):201ra120.
28. Diana M.A., Levenes C., Mackie K., Marty A. Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J. Neurosci. 2002, 22(1):200-208.
29. Dierssen M., Fotaki V., Martínez de Lagrán M., Gratacós M., Arbonés M., Fillat C., Estivill X. Neurobehavioral development of two mouse lines commonly used in transgenic studies. Pharmacol. Biochem. Behav. 2002, 73(1):19-25.
30. Dierssen M., Herault Y., Estivill X. Aneuploidy: from a physiological mechanism of variance to Down syndrome. Physiol. Rev. 2009, 89(3):887-920. (Review).
31. Dinerman J.L., Dawson T.M., Schell M.J., Snowman A., Snyder S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(10):4214-4218.
32. Erhardt J.A., Legos J.J., Johanson R.A., Slemmon J.R., Wang X. Expression of PEP-19 inhibits apoptosis in PC12 cells. Neuroreport 2000, 11:3719-3723.
33. Fernandez F., Garner C.C. Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome. Neurosci. Lett. 2007, 421(2):137-141. (Jun. 27).
34. Fierro L., Llano I. High endogenous calcium buffering in Purkinje cells from rat cerebellar slices. J. Physiol. 1996, 496(Pt 3):617-625.
35. Fink A.J., Englund C., Daza R.A., Pham D., Lau C., Nivison M., et al. Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip. J. Neurosci. 2006, 26:3066-3076.
36. Fox W.M. Reflex-ontogeny and behavioural development of the mouse. Anim. Behav. 1965, 13(2):234-241.
37. Gold D.A., Baek S.H., Schork N.J., Rose D.W., Larsen D.D., Sachs B.D., Rosenfeld M.G., Hamilton B.A. RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways. Neuron 2003, 40(6):1119-1131.
38. Gotti S., Chiavegatto S., Sica M., Viglietti-Panzica C., Nelson R.J., Panzica G. Alteration of NO-producing system in the basal forebrain and hypothalamus of Ts65Dn mice: an immunohistochemical and histochemical study of a murine model for Down syndrome. Neurobiol. Dis. 2004, 16(3):563-571.
39. Greif K.F., Erlander M.G., Tillakaratne N.J., Tobin A.J. Postnatal expression of glutamate decarboxylases in developing rat cerebellum. Neurochem. Res. 1991, 16(3):235-242.
40. Guedj F., Pereira P.L., Najas S., Barallobre M.J., Chabert C., Souchet B., et al. DYRK1A: a master regulatory protein controlling brain growth. Neurobiol. Dis. 2012, 46(1):190-203. (Erratum in: Neurobiol Dis 2012;47(2):294).
41. Guillou J.L., Rose G.M., Cooper D.M. Differential activation of adenylyl cyclases by spatial and procedural learning. J. Neurosci. 1999, 19(14):6183-6190.
42. Gutierrez-Castellanos N., Winkelman B.H., Tolosa-Rodriguez L., Devenney B., Reeves R.H., De Zeeuw C.I. Size does not always matter: Ts65Dn down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal sag treatment. J. Neurosci. 2013, 3(39):15408-15413.
43. Hansel C., de Jeu M., Belmeguenai A., Houtman S.H., Buitendijk G.H., Andreev D., et al. alphaCaMKII Is essential for cerebellar LTD and motor learning. Neuron 2006, 51(6):835-843.
44. Hubert V., Beaunieux H., Chételat G., Platel H., Landeau B., Danion J.M., et al. The dynamic network subserving the three phases of cognitive procedural learning. Hum. Brain Mapp. 2007, 28(12):1415-1429.
45. Hudmon A., Schulman H. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem. J. 2002, 364(Pt 3):593-611. (Review).
46. Ichikawa H., Sugimoto T. Peptide 19 in the rat vagal and glossopharyngeal sensory ganglia. Brain Res. 2005, 1038:107-112.
47. Ichikawa H., Morgan J.I., Sugimoto T. Peptide 19 in the dorsal root ganglion and the mesencephalic trigeminal tract nucleus of the adult rat. Brain Res. 1999, 821:231-235.
48. Ino H. Immunohistochemical characterization of the orphan nuclear receptor ROR alpha in the mouse nervous system. J. Histochem. Cytochem. 2004, 52(3):311-323. (Mar.).
49. Johanson R.A., Sarau H.M., Foley J.J., Slemmon J.R. Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II In situ. J. Neurosci. 2000, 20:2860-2866.
50. Kagami Y., Furuichi T. Investigation of differentially expressed genes during the development of mouse cerebellum. Brain Res. Gene Expr. Patterns 2001, 1(1):39-59.
51. Kahlem P., Sultan M., Herwig R., Steinfath M., Balzereit D., Eppens B., et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res. 2004, 14:1258-1267.
52. Kwon S.E., Chapman E.R. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 2011, 70(5):847-854.
53. Laffaire J., Rivals I., Dauphinot L., Pasteau F., Wehrle R., Larrat B., et al. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genomics 2009, 10:138.
54. Latash M.L. Motor coordination in Down syndrome: the role of adaptive changes. Perceptual-motor Behavior in Down Syndrome 2000, 199-224. Human Kinetics Inc. D.J. Weeks, R. Chua, D. Elliott (Eds.).
55. Leggio M.G., Neri P., Graziano A., Mandolesi L., Molinari M., Petrosini L. Cerebellar contribution to spatial event processing: characterization of procedural learning. Exp. Brain Res. 1999, 127(1):1-11.
56. Lein E.S., Callaway E.M., Albright T.D., Gage F.H. Redefining the boundaries of the hippocampal CA2 subfield in the mouse using gene expression and 3-dimensional reconstruction. J. Comp. Neurol. 2005, 485(1):1-10.
57. Llano I., Leresche N., Marty A. Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 1991, 6:565-574.
58. Luthi-Carter R., Hanson S.A., Strand A.D., Bergstrom D.A., Chun W., Peters N.L., et al. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 2002, 11(17):1911-1926.
59. Lyle R., Gehrig C., Neergaard-Henrichsen C., Deutsch S., Antonarakis S.E. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. Genome Res. 2004, 14:1268-1274.
60. McGuinness T.L., Lai Y., Greengard P. Ca2+/calmodulin-dependent protein kinase II. Isozymic forms from rat forebrain and cerebellum. J. Biol. Chem. 1985, 260(3):1696-1704.
61. Miller S.G., Kennedy M.B. Distinct forebrain and cerebellar isozymes of type II Ca2+/calmodulin-dependent protein kinase associate differently with the postsynaptic density fraction. J. Biol. Chem. 1985, 260(15):9039-9046.
62. Miller S., Yasuda M., Coats J.K., Jones Y., Martone M.E., Mayford M. Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron 2002, 36(3):507-519.
63. Molyneaux B.J., Arlotta P., Menezes J.R., Macklis J.D. Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 2007, 8(6):427-437. (Review).
64. Morice E., Andreae L.C., Cooke S.F., Vanes L., Fisher E.M., Tybulewicz V.L., Bliss T.V. Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn. Mem. 2008, 15(7):492-500. (Jul. 14).
65. Mostofsky S.H., Goldberg M.C., Landa R.J., Denckla M.B. Evidence for a deficit in procedural learning in children and adolescents with autism: implications for cerebellar contribution. J. Int. Neuropsychol. Soc. 2000, 6(7):752-759.
66. Mouton-Liger F., Thomas S., Rattenbach R., Magnol L., Larigaldie V., Ledru A., et al. PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+)/calmodulin-dependent kinase II-δ activation in mouse models of Down syndrome. J. Comp. Neurol. 2011, 519(14):2779-2802. (Erratum in: J Comp Neurol. 2011;519(17):3597).
67. Mugnaini E., Berrebi A.S., Dahl A.L., Morgan J.I. The polypeptide PEP-19 is a marker for Purkinje neurons in cerebellar cortex and cartwheel neurons in the dorsal cochlear nucleus. Arch. Ital. Biol. 1987, 126:41-67.
68. Murray K.D., Choudary P.V., Jones E.G. Nucleus- and cell-specific gene expression in monkey thalamus. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(6):1989-1994.
69. Olson L.E., Roper R.J., Baxter L.L., Carlson E.J., Epstein C.J., Reeves R.H. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev. Dyn. 2004, 230(3):581-589.
70. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press. Second edition.
71. Pennington B.F., Moon J., Edgin J., Stedron J., Nadel L. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev. 2003, 74(1):75-93.
72. Pérez-Cremades D., Hernández S., Blasco-Ibáñez J.M., Crespo C., Nacher J., Varea E. Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome. J. Neural. Transm. 2010, 117(4):445-455.
73. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
74. Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge Vivier C., Delorenzi M., Gehrig C., Descombes P., Sherman S., Dagna Bricarelli F., Baldo C., Novelli A., Dallapiccola B., Antonarakis S.E. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am. J. Hum. Genet. 2007, 81(2):252-263.
75. Przyborski S.A., Smith S., Wood A. Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 2003, 21(4):459-471.
76. Putkey J.A., Kleerekoper Q., Gaertner T.R., Waxham M.N. A new role for IQ motif proteins in regulating calmodulin function. J. Biol. Chem. 2003, 278:49667-49670.
77. Putkey J.A., Waxham M.N., Gaertner T.R., Brewer K.J., Goldsmith M., Kubota Y., Kleerekoper Q.K. Acidic/IQ motif regulator of calmodulin. J. Biol. Chem. 2008, 283:1401-1410.
78. Raz N., Torres I.J., Briggs S.D., Spencer W.D., Thornton A.E., Loken W.J., Gunning F.M., McQuain J.D., Driesen N.R., Acker J.D. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 1995, 45(2):356-366.
79. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T., Davisson M.T. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 1995, 11(2):177-184. (Oct.).
80. Reymond A., Marigo V., Yaylaoglu M.B., Leoni A., Ucla C., Scamuffa N., et al. Human chromosome 21 gene expression atlas in the mouse. Nature 2002, 420:582-586.
81. Sago H., Carlson E.J., Smith D.J., Kilbridge J., Rubin E.M., Mobley W.C., et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6256-6261.
82. Sago H., Carlson E.J., Smith D.J., Rubin E.M., Crnic L.S., Huang T.T., Epstein C.J. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 2000, 48(5):606-613. (Nov.).
83. Sala A., Scaturro M., Proia P., Schiera G., Balistreri E., Aflalo-Rattenbach R., et al. Cloning of a rat-specific long PCP4/PEP19 isoform. Int. J. Mol. Med. 2007, 19:501-509.
84. Sangameswaran L., Hempstead J., Morgan J.I. Molecular cloning of a neuron-specific transcript and its regulation during normal and aberrant cerebellar development. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(14):5651-5655.
85. Schilling K., Oberdick J. The treasury of the commons: making use of public gene expression resources to better characterize the molecular diversity of inhibitory interneurons in the cerebellar cortex. Cerebellum 2009, 8(4):477-489.
86. Shen X., Valencia C.A., Szostak J.W., Dong B., Liu R. Scanning the human proteome for calmodulin-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(17):5969-5974. (Erratum in: Proc Natl Acad Sci U S A. 2005;102(27):9734. Szostak, Jack [corrected to Szostak, Jack W]).
87. Simons S.B., Escobedo Y., Yasuda R., Dudek S.M. Regional differences in hippocampal calcium handling provide a cellular mechanism for limiting plasticity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(33):14080-14084.
88. Slemmon J.R., Hughes C.M., Campbell G.A., Flood D.G. Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. J. Neurosci. 1994, 14(4):2225-2235.
89. Slemmon J.R., Morgan J.I., Fullerton S.M., Danho W., Hilbush B.S., Wengenack T.M. Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J. Biol. Chem. 1996, 271:15911-15917.
90. Steward O. mRNA at synapses, synaptic plasticity, and memory consolidation. Neuron 2002, 36(3):338-340.
91. Steward O., Schuman E.M. Compartmentalized synthesis and degradation of proteins in neurons. Neuron 2003, 40(2):347-359.
92. Teichert A.M., Miller T.L., Tai S.C., Wang Y., Bei X., Robb G.B., et al. In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene. Am. J. Physiol. Heart Circ. Physiol. 2000, 278(4):H1352-H1361.
93. Teyssier J.R., Ragot S., Chauvet-Gélinier J.C., Trojak B., Bonin B. Activation of a δFOSB dependent gene expression pattern in the dorsolateral prefrontal cortex of patients with major depressive disorder. J. Affect. Disord. 2011, 133(1-2):174-178.
94. Thomas S., Thiery E., Aflalo R., Vayssettes C., Verney C., Berthuy I., Créau N. PCP4 is expressed in ectoderm and neurectoderm derivatives during mouse embryogenesis. Gene Expr. Patterns 2003, 3:93-97.
95. Thomas S., Aflalo-Rattenbach R., Mouton-Liger F., Créau N. PCP4 (PEP-19): function, regulation and neurodegenerative diseases. Molecular Bases of Neurodegeneration. I. Res. Sign. Pub. 2005, 199-212. di Liegro, G. Savettieri (Eds.).
96. Utal A.K., Stopka A.L., Roy M., Coleman P.D. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. Neuroscience 1998, 86:1055-1063.
97. Vallano M.L., Beaman-Hall C.M., Mathur A., Chen Q. Astrocytes express specific variants of CaM KII delta and gamma, but not alpha and beta, that determine their cellular localizations. Glia 2000, 30(2):154-164.
98. van Welie I., Smith I.T., Watt A.J. The metamorphosis of the developing cerebellar microcircuit. Curr. Opin. Neurobiol. 2011, 21(2):245-253.
99. van Woerden G.M., Hoebeek F.E., Gao Z., Nagaraja R.Y., Hoogenraad C.C., Kushner S.A., et al. betaCaMKII controls the direction of plasticity at parallel fiber-Purkinje cell synapses. Nat. Neurosci. 2009, 12(7):823-825.
100. Wang X., Xiong L.W., El Ayadi A., Boehning D., Putkey J.A. The calmodulin regulator protein, PEP-19, sensitizes ATP-induced Ca2+ release. J. Biol. Chem. 2013, 288(3):2040-2048.
101. Watakabe A., Hirokawa J., Ichinohe N., Ohsawa S., Kaneko T., Rockland K.S., Yamamori T. Area-specific substratification of deep layer neurons in the rat cortex. J. Comp. Neurol. 2012, 520(16):3553-3573.
102. Wei P., Blundon J.A., Rong Y., Zakharenko S.S., Morgan J.I. Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4-null mice. Mol. Cell. Biol. 2011, 31(14):2838-2844.
103. Wu L., Wells D., Tay J., Mendis D., Abbott M.A., Barnitt A., et al. CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha-CaMKII mRNA at synapses. Neuron 1998, 21(5):1129-1139.
104. Ziai R., Pan Y.C., Hulmes J.D., Sangameswaran L., Morgan J.I. Isolation, sequence, and developmental profile of a brain-specific polypeptide, PEP-19. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:8420-8423.